Biologic Knee Reconstruction A Surgeons Guide
Governmental Regulation and Availability and Accessibility to Patients
Publication
, Chapter
Godin, JA; Mather, RC
January 1, 2024
To better understand the regulation of cartilage repair products, one must first be familiar with the myriad terms and specifics of the drug, device, and biologic regulatory pathways.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Godin, J. A., & Mather, R. C. (2024). Governmental Regulation and Availability and Accessibility to Patients. In Biologic Knee Reconstruction A Surgeons Guide (pp. 221–226). https://doi.org/10.1201/9781003522768-33
Godin, J. A., and R. C. Mather. “Governmental Regulation and Availability and Accessibility to Patients.” In Biologic Knee Reconstruction A Surgeons Guide, 221–26, 2024. https://doi.org/10.1201/9781003522768-33.
Godin JA, Mather RC. Governmental Regulation and Availability and Accessibility to Patients. In: Biologic Knee Reconstruction A Surgeons Guide. 2024. p. 221–6.
Godin, J. A., and R. C. Mather. “Governmental Regulation and Availability and Accessibility to Patients.” Biologic Knee Reconstruction A Surgeons Guide, 2024, pp. 221–26. Scopus, doi:10.1201/9781003522768-33.
Godin JA, Mather RC. Governmental Regulation and Availability and Accessibility to Patients. Biologic Knee Reconstruction A Surgeons Guide. 2024. p. 221–226.